Related Experiment Video
Updated: Oct 21, 2025

A Porcine Model of Acute Autologous Pulmonary Embolism
Published on: September 6, 2024
Use of direct oral anticoagulants for acute pulmonary embolisms in obesity: a propensity-matched, multicentre
Chinthaka B Samaranayake1, Gregory Keir1,2, Simon A A Slader2
1Faculty of Medicine, University of Queensland, Brisbane, Australia.
Abstract:
Assessment of efficacy and safety of DOACs in treatment of pulmonary embolisms in obese patients provides reassurance that treatment with DOACs carries similar rates of recurrent VTE and bleeding complications to warfarin https://bit.ly/2VdrSXX.
Related Concept Videos
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Pulmonary Embolism I: Introduction
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis III: Interprofessional Care
Drug Dosing: Obese Patients

